Oaktree Specialty Lending plans $300M 7% 2031 notes
Oaktree Specialty Lending Corporation agreed to issue $300 million of 7.000% notes due 2031, generating expected net proceeds of about $296.5 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Oaktree Specialty Lending Corporation (OCSL) entered into an underwriting agreement on September 9, 2026 in connection with the issuance and sale of $300.0 million aggregate principal amount of 7.000% Notes due 2031. The closing of the offering is expected to occur on September 16, 2026, subject to customary closing conditions. Net proceeds to the company are expected to be $296.5 million after an underwriting discount of $2.6 million and estimated offering expenses of approximately $0.8 million, with the notes offered under its effective shelf registration statement on Form N-2.
8-K Event Classification
Key Figures
Key Terms
Underwriting Agreement financial
aggregate principal amount financial
shelf registration statement regulatory
prospectus supplement regulatory
net proceeds financial
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OCSL announce regarding new debt securities in this 8-K?
What net proceeds will OCSL (OCSL) receive from the 7.000% Notes due 2031 offering?
What are the key terms of OCSL’s new notes described in the filing?
When is the closing of OCSL’s 7.000% Notes due 2031 offering expected?
Which underwriters are involved in OCSL’s $300 million notes offering?
AI-generated analysis. How Rhea-AI works. Not financial advice.